FREED played a major role in recruiting subjects for the Anorexia Nervosa Genetics Initiative (ANGI) – the largest genetics study on eating disorders that has ever been undertaken anywhere in the world. This research is determining the genes that cause or increase the risk of developing eating disorders.
FREED has developed a partnership with Walden Behavioral Care (WBC) whereby the Foundation has access to a unique, large and growing patient population that is accessible for research studies, clinical trials, development of patient registries, sample collection and resource building.
FREED has several innovative studies under development or execution to advance discoveries in eating disorders. For example, we are collaborating with researchers at other academic institutions to determine the relationship between eating disorders and factors such as heart rate variability and genetics.